While the study only involved narcolepsy type 1, previous work has shown that orexin signaling may be deficient in other ...

Rimegepant is already FDA-approved for acute treatment of migraine and preventive treatment of episodic migraine in adults.

Two new studies led by researchers at Washington University School of Medicine in St. Louis have identified a possible way to block the progression of several forms of blood cancer using a drug ...

Researchers from the University at Albany and NYU Grossman School of Medicine have found a way to block a key cellular ...

The company intends to meet with the FDA to discuss results that showed a level of improvement on a marker of muscle ...

Bristol Myers Squibb have extended their research collaboration aimed at designing and optimizing small-molecule drugs for ...

Many drug trials are vetted by companies with ties to the drugmakers, raising concerns about conflicts of interest and patient safety. Credit...Blake Cale Supported by By Walt Bogdanich Carson Kessler ...

April 17 (UPI) --People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its latest clinical testing, the Indianapolis-based drugmaker ...

Scientists have developed compounds that selectively block a crucial interaction between RAS and the enzyme PI3K, a driver of ...

Scotland’s first national drug testing and research laboratory has been announced. The Scottish Government said the lab will ...

The U.S. Food and Drug Administration (FDA) has approved a new nonhormonal treatment to help women manage menopause symptoms ...

Researchers in Sweden are testing a 250-year-old medicine in patients with one of the world's deadliest cancers.